Barclays Portfolio holdings
Barclays PLC, founded in 1690 by goldsmith bankers in London, is a British multinational financial institution headquartered in London, operating as one of the world’s oldest banks with a significant presence in investment banking, retail banking, and wealth management. Managing billions in assets, Barclays serves millions of customers globally through its retail arm (notably in the UK) and its investment banking division, which excels in trading, mergers and acquisitions, and capital markets, competing with Wall Street giants. The bank has navigated challenges like the 2008 financial crisis—opting for private funding over a government bailout—and has since focused on restructuring, digital innovation, and sustainable finance initiatives. With a rich history and a modern global footprint, Barclays remains a key player in both UK and international financial markets.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
State Street SPDR S&P 500 ETF Trust
SPY
|
+$1.74B |
| 2 |
Invesco QQQ Trust
QQQ
|
+$760M |
| 3 |
Alibaba
BABA
|
+$429M |
| 4 |
Stellantis
STLA
|
+$372M |
| 5 |
CERN
Cerner Corp
CERN
|
+$304M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Apple
AAPL
|
+$1.85B |
| 2 |
Microsoft
MSFT
|
+$1.75B |
| 3 |
Alphabet (Google) Class A
GOOGL
|
+$1.22B |
| 4 |
Amazon
AMZN
|
+$1.04B |
| 5 |
iShares US Real Estate ETF
IYR
|
+$924M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 22.06% |
| 2 | Financials | 14.44% |
| 3 | Healthcare | 10.25% |
| 4 | Consumer Discretionary | 9.7% |
| 5 | Communication Services | 8.12% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
2501
Option Care Health
OPCH
$3.55B
| $779K | ﹤0.01% |
+27,279
| New | +$685K |
|
|
MACA
2502
DELISTED
Moringa Acquisition Corp Class A Ordinary Shares
MACA
| $779K | ﹤0.01% |
+79,592
| New | +$775K |
|
2503
DXC Technology
DXC
$1.78B
| $778K | ﹤0.01% |
23,851
-68,718
| -74% | -$2.27M |
|
2504
Haemonetics
HAE
$3.94B
| $776K | ﹤0.01% |
12,258
-62,235
| -84% | -$3.38M |
|
2505
Tronox
TROX
$909M
| $776K | ﹤0.01% |
39,169
-119,983
| -75% | -$2.6M |
|
2506
AMERISAFE
AMSF
$564M
| $775K | ﹤0.01% |
15,590
-9,459
| -38% | -$483K |
|
2507
Interface
TILE
$2.03B
| $775K | ﹤0.01% |
57,157
-30,144
| -35% | -$416K |
|
|
TUP
2508
DELISTED
Tupperware Brands Corporation
TUP
| $775K | ﹤0.01% |
39,890
-23,867
| -37% | -$407K |
|
2509
Quanex
NX
$883M
| $774K | ﹤0.01% |
36,954
-21,251
| -37% | -$484K |
|
2510
Enviri
NVRI
$651M
| $773K | ﹤0.01% |
63,206
-39,147
| -38% | -$575K |
|
2511
DHT Holdings
DHT
$2.98B
| $771K | ﹤0.01% |
132,864
-84,626
| -39% | -$466K |
|
2512
SunCoke Energy
SXC
$714M
| $770K | ﹤0.01% |
86,488
-33,267
| -28% | -$262K |
|
|
STSA
2513
DELISTED
Satsuma Pharmaceuticals, Inc. Common Stock
STSA
| $769K | ﹤0.01% |
+202,478
| New | +$912K |
|
2514
John B. Sanfilippo & Son
JBSS
$993M
| $767K | ﹤0.01% |
9,205
-3,768
| -29% | -$312K |
|
|
AVTA
2515
DELISTED
Avantax, Inc. Common Stock
AVTA
| $766K | ﹤0.01% |
39,136
-24,378
| -38% | -$442K |
|
|
FARO
2516
DELISTED
Faro Technologies
FARO
| $763K | ﹤0.01% |
14,685
-9,068
| -38% | -$507K |
|
2517
1st Source
SRCE
$2.18B
| $762K | ﹤0.01% |
16,467
-17,514
| -52% | -$865K |
|
2518
STAAR Surgical
STAA
$1.21B
| $762K | ﹤0.01% |
9,535
-235,797
| -96% | -$17.6M |
|
2519
Nabors Industries
NBR
$1.25B
| $761K | ﹤0.01% |
+4,981
| New | +$625K |
|
|
OCDX
2520
DELISTED
Ortho Clinical Diagnostics Holdings plc Ordinary Shares
OCDX
| $761K | ﹤0.01% |
+40,774
| New | +$734K |
|
2521
Sensient Technologies
SXT
$5.37B
| $760K | ﹤0.01% |
9,066
-53,887
| -86% | -$4.54M |
|
2522
Sprout Social
SPT
$514M
| $758K | ﹤0.01% |
+9,463
| New | +$648K |
|
2523
Usana Health Sciences
USNA
$422M
| $758K | ﹤0.01% |
9,544
-8,071
| -46% | -$728K |
|
|
BGFV
2524
DELISTED
Big 5 Sporting Goods
BGFV
| $756K | ﹤0.01% |
44,094
-16,728
| -28% | -$298K |
|
2525
Encompass Health
EHC
$11.2B
| $756K | ﹤0.01% |
13,348
-59,924
| -82% | -$3.13M |
|
Similar funds
Barclays's Q1 2022 Portfolio in Review
As of Q1 2022, Barclays held 5,876 positions worth $128B, down 52% from $268B the previous quarter. Its ten largest holdings account for 22% of the portfolio.
Barclays withdrew a net $131B in Q1 2022, closing 907 positions and reducing 2,310 holdings. Its most notable exit was Nuance Communications, Inc., an estimated $631M position sold in full.
By sector, the portfolio is most concentrated in Technology at 22% of assets, up from 15% a quarter earlier, followed by Financials and Healthcare.
Against the trend, Barclays opened a new position in Stellantis worth $331M.
- Barclays's largest Q1 2022 buy was Stellantis: 20,333,315 shares worth $331M.
- Barclays added most to State Street SPDR S&P 500 ETF Trust in Q1 2022, an estimated $1.74B increase.
- Barclays's biggest Q1 2022 reduction was Apple, cutting an estimated $1.85B.
- Barclays fully exited Nuance Communications, Inc. in Q1 2022, selling an estimated $631M.
- Barclays's ten largest holdings make up 22% of its $128B portfolio in Q1 2022.
- Barclays opened 1,592 new positions and closed 907 in Q1 2022.
- Barclays's portfolio value fell 52% quarter-over-quarter to $128B.
Based on Barclays's 13F filing for Q1 2022, filed 16 May 2022.